InvestorsHub Logo
Followers 20
Posts 2394
Boards Moderated 0
Alias Born 01/28/2012

Re: None

Monday, 09/17/2012 6:25:38 PM

Monday, September 17, 2012 6:25:38 PM

Post# of 30372
Press release today on publication regarding tolnaftate with nexact:

http://finance.yahoo.com/news/apricus-biosciences-announces-publication-journal-192053054.html

From the following website, I counted 32 brand names for tolnaftate products for stopping the growth of fungi that cause skin infections, including athlete's foot, jock itch, and ringworm. I would think that one of these product companies would have to take an interest in marketing the nexact product OTC, charging more but advertising that the product is XX% more effective than the others.

http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0000730/

I am not sure what the company's strategy is to get this (and others in the pipeline) to market.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SEEL News